BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 20374692)

  • 1. Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW.
    Fizzell J; Campbell-Lloyd S; Hallett AJ; Lowbridge CP; Meijer D; Tyner SE
    N S W Public Health Bull; 2010; 21(1-2):32-5. PubMed ID: 20374692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pandemic (H1N1) 2009 influenza in NSW: an overview of the public health response.
    Spokes PJ; Cretikos MA; Ward JG
    N S W Public Health Bull; 2010; 21(1-2):4-9. PubMed ID: 20374687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and quarantine during pandemic (H1N1) 2009 influenza in NSW: the operational experience of public health units.
    Binns PL; Sheppeard V; Staff MP
    N S W Public Health Bull; 2010; 21(1-2):10-5. PubMed ID: 20374688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
    Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
    Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].
    Uhnoo I; Bergquist C
    Lakartidningen; 2009 Jul 8-21; 106(28-29):1814-9. PubMed ID: 19685621
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
    Torun SD; Torun F
    Vaccine; 2010 Aug; 28(35):5703-10. PubMed ID: 20600497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
    Enserink M
    Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
    [No Abstract]   [Full Text] [Related]  

  • 10. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.
    Chlibek R; Anca I; André F; Bakir M; Ivaskeviciene I; Mangarov A; Mészner Z; Perenovska P; Prymula R; Richter D; Salman N; Simurka P; Tamm E; Toplak N; Usonis V
    Vaccine; 2010 May; 28(22):3758-66. PubMed ID: 20380902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
    Zijtregtop EA; Wilschut J; Koelma N; Van Delden JJ; Stolk RP; Van Steenbergen J; Broer J; Wolters B; Postma MJ; Hak E
    Vaccine; 2009 Dec; 28(1):207-27. PubMed ID: 19800997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from the NSW laboratory response to pandemic (H1N1) 2009 influenza.
    Adamson S; Fizzell J; Dwyer DE; Rawlinson W; Armstrong PK
    N S W Public Health Bull; 2010; 21(1-2):36-8. PubMed ID: 20374693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responding to pandemic (H1N1) 2009 influenza in Aboriginal communities in NSW through collaboration between NSW Health and the Aboriginal community-controlled health sector.
    Rudge S; Massey PD
    N S W Public Health Bull; 2010; 21(1-2):26-9. PubMed ID: 20374691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pandemic threat: are we prepared?
    Lewis KK
    Issue Brief (Mass Health Policy Forum); 2006 Jun; (29):1-14. PubMed ID: 16886304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Planning preventive vaccination of pandemic H1N1 influenza].
    Chevillotte J
    Rev Infirm; 2009 Oct; (154):10. PubMed ID: 19894292
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflections on public health surveillance of pandemic (H1N1) 2009 influenza in NSW.
    Churches T; Conaty SJ; Gilmour RE; Muscatello DJ
    N S W Public Health Bull; 2010; 21(1-2):19-25. PubMed ID: 20374690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of the new pandemic influenza A/H1N1/2009 virus: virology, epidemiology, clinical and public health aspects.
    Tang JW; Shetty N; Lam TT
    Curr Opin Pulm Med; 2010 May; 16(3):235-41. PubMed ID: 20375785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
    Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
    N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fear and expectations].
    Haug C
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1619. PubMed ID: 19721471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.